Skip to content

Study to check the improvement in hair health.

Clinical Evaluation of Efficacy and Safety of Keranyaa in improving hair health including hair volume, hair softness, hair strength in healthy adult volunteers

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047219
Enrollment
34
Registered
2022-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Hair oil: Apply about 4 pumps in a bowl of Keranyaa and apply thoroughly on different areas of scalp. Use your fingertips to spread the oil all over the scalp, going through partings on

Sponsors

Transformative Learning Solutions Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Female and Male subjects in general good health. 2.Subjects in the age group 18-55 years (both the ages inclusive). 3.Subjects complaining of hair fall and damage. 4.Subjects willing to give a written informed consent and willing to abide by and comply with the study protocol. 5.Subjects falling under Grade 3 - Grade 6 of hair lossseverity grade evaluated as per MSCR photo numerical 10-point scale (Linear scale for assessment purpose-In Use Scale)

Exclusion criteria

Exclusion criteria: 1.Subjects who have undergone hair growth treatment within 3 months before screening into the study. 2.Subjects having any active scalp disease which may interfere in the study â?? dermatologistâ??s judgement. 3.Subjects who have undergone chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study. 4.Subjects who have history of alcoholism, smoking, crash dieting and/ or psychiatric disorder including trichotillomania. 5.Subjects who have had hair transplant, who have taken pharmaceutical product which cause hirsutism (ex. phenytoin) and finasteride for androgenic alopecia, under medical treatment for hair problems. 6. Subjects taking food or vitamin supplements that may compromise the study 7.Subjects who wear wig or hair extensions 8.Subjects on oral medications, undergoing any chemical hair salon treatment-straightening / perming / color/ henna which will compromise the study. 9.Subjects with chronic illness which may influence the study. 10.Subjects who are pregnant or lactating or nursing as established with medical history 11.Menopausal female subjects as determined by medical history. 12.Subjects participating in other similar cosmetic or therapeutic trial within last three months. 13.Subjects with any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.

Design outcomes

Primary

MeasureTime frame
1. Improvement in hair volume 2. Improvement in hair softness 3. Improvement in hair strength 4. Reduction in hair fall 5. Improvement in scalp conditionTimepoint: Day1, Day 30 and Day 60

Secondary

MeasureTime frame
The product safety profile by dermatologistTimepoint: Day1, Day 30 and Day 60

Countries

India

Contacts

Public ContactSudhanthiran S

Transformative Learning Solution Pvt. Ltd.

satyendra.kumar@transformative.in9891253516

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026